Notable Call Buying Activity in Teva Pharma (TEVA) Continues -Susquehanna
Tweet
Share
E-mail
Get Alerts TEVA Hot Sheet
Price: $39.19 -2.56%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.1%
Revenue Growth %: -5.1%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.1%
Revenue Growth %: -5.1%
Join SI Premium – FREE
Susquehanna options strategist Alison Edwards notes continued buying activity Teva Pharma (NYSE: TEVA) , as an opening investor bought 15k Jan 15 Calls, most for $1.10, creating ~750k shares to buy.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oppenheimer Starts Teva Pharma (TEVA) at Outperform
- Increasing unusual put option volume: BUG NKTR XEL MNST NTRA BAM BURL TMF ALT AKAM WMB MPLX TECK
- Active options: GOOGL MSTR SOFI PLTR GME CRWV NBIS AVGO SNDK
Create E-mail Alert Related Categories
Options, Trader TalkRelated Entities
Susquehanna International Group of CompaniesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
